Pneumococci stimulate the production of the inducible nitric oxide synthase and nitric oxide by murine macrophages

Journal of Infectious Diseases

Volumn 178, Issue 6, 1998, Pages 1649-1657

  Orman, Karen L ^a   Shenep, Jerry L ^b   English, B Keith ^b  

^a LE BONHEUR CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; ENZYME ACTIVATION; ENZYME INDUCTION; HOST RESISTANCE; INFECTION RESISTANCE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BACTEREMIA; CELL LINE; CELL WALL; ENZYME INDUCTION; INTERFERON-GAMMA, RECOMBINANT; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXACILLIN; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0031768041     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314526     Document Type: Article

References (18)

1. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997;100:2417-23.
2. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994;78:15-8.
3. Nicholson S, Bonecini-Almeida MG, Lapa e Silva JR, et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996;183:2293-302.
4. Anstey NM, Weinberg JB, Hassanali MY, et al. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med 1996;184:557-67.
5. Reiling N, Ulmer AJ, Duchrow M, Ernst M, Flad HD, Hauschildt S. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol 1994;24:1941-4.
6. Snell JC, Chernyshev O, Gilbert DL, Colton CA. Polyribonucleotides induce nitric oxide production by human monocyte-derived macrophages. J Leukoc Biol 1997;62:369-73.
7. Thiemermann C. Nitric oxide and septic shock. Gen Pharmacol 1997;29:159-66.
8. Beutler B. The biology of cachectin/TNF - a primary mediator of the host response. Annu Rev Immunol 1989;7:625-55.
9. Gardlund B, Sjolin J, Nilsson A, Roll M, Wickerts CJ, Wretlind B. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis 1995;172:296-301.
10. Bone RC. Gram-positive organisms and sepsis. Arch Intern Med 1994;154:26-34.
11. Hinshaw LB, Emerson TE Jr, Taylor FB Jr, et al. Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody. J Trauma 1992;33:568-73.
12. de Bont ES, Martens A, van Raan J, et al. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 plasma levels in neonatal sepsis. Pediatr Res 1993;33:380-3.
13. Stevens DL, Bryant AE, Hackett SP, et al. Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. J Infect Dis 1996;173:619-26.
14. Hattor Y, Kasai K, Akimoto K, Thiemermann C. Induction of NO synthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: involvement of a CD14-dependent pathway. Biochem Biophys Res Commun 1997;233:375-9.
15. Kengatharan M, De Kimpe SJ, Thiemermann C. Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages. Br J Pharmacol 1996;117:1163-70.
16. De Kimpe SJ, Kengatharan M, Thiemermann C, Vane JR. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Natl Acad Sci USA 1995;92:10359-63.
17. English BK, Patrick CC, Orlicek SL, McCordic R, Shenep JL. Lipoteichoic acid from viridans streptococci induces the production of tumor necrosis factor and nitric oxide by murine macrophages. J Infect Dis 1996;174:1348-51.
18. Sriskandan S, Moyes D, Buttery LK, et al. The role of nitric oxide in experimental murine sepsis due to pyrogenic exotoxin A-producing Streptococcus pyogenes. Infect Immun 1997;65:1767-72.